Clinical Trials List
2017-01-15 - 2020-01-31
Others
Terminated2
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Yu-Min Yeh Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Sin-Syue Li Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Taiwan National PI
Co-Principal Investigator
- Tsai-Sheng Yang Division of Hematology & Oncology
- 呂嘉偉 Division of Radiology
- Wen-Cheng Chang Division of Hematology & Oncology
- Hung-Chih Hsu Division of Hematology & Oncology
- Chih-Liang Wang Division of Hematology & Oncology
- Tse-Ching Chen Division of Others -
- Yung-Chang Lin Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
1 Stop recruiting
Audit
CRO
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
4 participants
-
Global
283 participants
